__timestamp | AstraZeneca PLC | Pfizer Inc. |
---|---|---|
Wednesday, January 1, 2014 | 5579000000 | 8393000000 |
Thursday, January 1, 2015 | 5997000000 | 7690000000 |
Friday, January 1, 2016 | 5890000000 | 7872000000 |
Sunday, January 1, 2017 | 5757000000 | 7657000000 |
Monday, January 1, 2018 | 5932000000 | 8006000000 |
Tuesday, January 1, 2019 | 5958000000 | 8650000000 |
Wednesday, January 1, 2020 | 5991000000 | 9405000000 |
Friday, January 1, 2021 | 9736000000 | 13829000000 |
Saturday, January 1, 2022 | 9762000000 | 11428000000 |
Sunday, January 1, 2023 | 11015000000 | 10679000000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, AstraZeneca PLC and Pfizer Inc. have been at the forefront of this race. From 2014 to 2023, Pfizer consistently outpaced AstraZeneca in R&D spending, with an average annual investment of approximately $9.4 billion, compared to AstraZeneca's $7.2 billion. However, AstraZeneca's R&D expenditure surged by 95% from 2017 to 2023, peaking at $10.9 billion in 2023, reflecting its commitment to innovation. Meanwhile, Pfizer's R&D spending reached its zenith in 2021 at $13.8 billion, driven by its COVID-19 vaccine development. This data underscores the dynamic nature of pharmaceutical R&D, where strategic investments can lead to groundbreaking advancements and market leadership.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and AstraZeneca PLC
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and HUTCHMED (China) Limited
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: Pfizer Inc. and Insmed Incorporated
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Research and Development: Comparing Key Metrics for Pfizer Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Travere Therapeutics, Inc.